Natraj Proteins Ltd
Natraj Proteins Ltd (NATRAJPR) last reported results for the quarter ended Jun 2026, with sales of ₹31.42 crore and net profit of ₹2.11 crore. The stock last traded at ₹39, a market capitalisation of ₹14.6 crore, on a P/E of 3.29. Over the past 52 weeks the stock has ranged between ₹28 and ₹45.8. Figures are as of 6 Oct 2026 and are not real time.
Natraj Proteins Ltd share price and key metrics
- Current price
- ₹39
- Market cap
- ₹14.6 cr
- Stock P/E
- 3.29
- Book value
- ₹89
- ROE
- 3.48%
- ROCE
- 5.63%
- Dividend yield
- 0.00%
- 52w high / low
- 45.8/28.0
Metrics as of 6 Oct 2026. Not real time.
Track Natraj Proteins Ltd
Cruxal reads every Natraj Proteins Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Natraj Proteins Ltd growth and returns
- 10 Years
- -7%
- 5 Years
- -7%
- 3 Years
- -11%
- TTM
- 0%
- 10 Years
- 8%
- 5 Years
- 24%
- 3 Years
- 17%
- TTM
- 580%
- 10 Years
- 3%
- 5 Years
- -16%
- 3 Years
- -9%
- 1 Year
- -7%
- 10 Years
- 0%
- 5 Years
- -1%
- 3 Years
- -12%
- Last Year
- 3%
Natraj Proteins Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹31.42 cr, up 18.3% from ₹26.56 cr a year earlier. Net profit turned positive at ₹2.11 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 22.79 | 33.41 | 23.06 | 26.56 | 26.92 | 28.77 | 18.87 | 31.42 |
| Expenses | 23.19 | 32.78 | 21.19 | 27.19 | 27.94 | 25.23 | 17.15 | 28.61 |
| Operating profit | -0.4 | 0.63 | 1.87 | -0.63 | -1.02 | 3.54 | 1.72 | 2.81 |
| OPM % | -1.76% | 1.89% | 8.11% | -2.37% | -3.79% | 12.30% | 9.11% | 8.94% |
| Other income | 0.06 | 0.02 | 0.35 | 0.07 | 0.05 | 0.04 | 0.1 | 0.05 |
| Interest | 0.55 | 0.5 | 0.66 | 0.55 | 0.58 | 0.59 | 0.66 | 0.63 |
| Depreciation | 0.09 | 0.1 | 0.07 | 0.09 | 0.09 | 0.09 | 0.11 | 0.11 |
| Profit before tax | -0.98 | 0.05 | 1.49 | -1.2 | -1.64 | 2.9 | 1.05 | 2.12 |
| Tax % | 4.08% | 40.00% | 15.44% | 0.83% | 0.61% | 0.34% | -5.71% | 0.47% |
| Net profit | -1.01 | 0.03 | 1.26 | -1.21 | -1.65 | 2.89 | 1.11 | 2.11 |
| EPS (₹) | -2.70 | 0.08 | 3.36 | -3.23 | -4.40 | 7.71 | 2.96 | 5.63 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Natraj Proteins Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 258 | 196 | 191 | 154 | 146 | 145 | 144 | 194 | 118 | 101 | 106 |
| Operating profit | 4 | 6 | 6 | 5 | 3 | 14 | 3 | -9 | 1 | 4 | 7 |
| OPM % | 1.5% | 3.3% | 3.1% | 2.9% | 2.1% | 10% | 2.2% | -4.8% | 0.9% | 3.6% | 7% |
| Net profit | 0 | 2 | 1 | 0 | 0 | 9 | 1 | -13 | -1 | 1 | 4 |
| EPS (₹) | 0.61 | 4.30 | 3.07 | 0.91 | 1.04 | 24.98 | 1.89 | -33.41 | -3.90 | 3.04 | 11.90 |
TTM is the trailing twelve months to the most recent quarter.
Natraj Proteins Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves | 29 | 31 | 32 | 32 | 32 | 42 | 42 | 30 | 28 | 30 |
| Borrowings | 19 | 54 | 31 | 31 | 22 | 27 | 34 | 40 | 23 | 36 |
| Other liabilities | 14 | 18 | 6 | 4 | 10 | 3 | 9 | 4 | 4 | 7 |
| Total liabilities | 65 | 106 | 72 | 71 | 68 | 76 | 89 | 78 | 59 | 76 |
| Fixed assets | 4 | 4 | 4 | 3 | 3 | 4 | 4 | 5 | 5 | 6 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Other assets | 61 | 102 | 69 | 68 | 66 | 71 | 83 | 72 | 52 | 70 |
| Total assets | 65 | 106 | 72 | 71 | 68 | 76 | 89 | 78 | 59 | 76 |
As reported by the company. Total assets equal total liabilities by construction.
Natraj Proteins Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 3 | -37 | 30 | 2 | 9 | 6 | 3 | -6 | 22 | -14 |
| Cash from investing | -2 | 3 | 2 | 0 | -0 | -3 | -3 | 0 | -2 | 3 |
| Cash from financing | -4 | 31 | -28 | -4 | -10 | 2 | -2 | 3 | -20 | 11 |
| Net cash flow | -3 | -3 | 4 | -2 | -2 | 5 | -2 | -2 | -1 | 0 |
| Free cash flow | 3 | -37 | 29 | 2 | 9 | 4 | 1 | -6 | 21 | -14 |
| CFO / operating profit | 67% | -583% | 500% | 42% | 264% | 63% | 96% | 60% | 1,970% | -378% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Natraj Proteins Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 8% | 9% | 7% | 6% | 4% | 21% | 4% | -12% | 2% | 6% |
| Debtor days | 16 | 27 | 38 | 42 | 37 | 43 | 31 | 32 | 28 | 27 |
| Inventory days | 55 | 174 | 87 | 108 | 122 | 119 | 154 | 84 | 109 | 207 |
| Days payable | 16 | 32 | 8 | 5 | 20 | 3 | 18 | 3 | 4 | 17 |
| Cash conversion cycle | 55 | 168 | 117 | 145 | 139 | 159 | 167 | 113 | 133 | 217 |
| Working capital days | 27 | 50 | 50 | 68 | 73 | 81 | 82 | 38 | 54 | 68 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Natraj Proteins Ltd shareholding pattern
Promoters held 41.82% at Jun 2026, broadly unchanged since Jun 2025. DIIs 1.90%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 42.63% | 42.23% | 42.16% | 42.16% | 42.14% | 41.82% | 41.82% | 41.82% |
| DIIs | 1.93% | 1.93% | 1.93% | 1.93% | 1.93% | 1.93% | 1.90% | 1.90% |
| Public | 55.43% | 55.85% | 55.91% | 55.91% | 55.93% | 56.25% | 56.29% | 56.28% |
| No. of shareholders | 2,911 | 2,996 | 3,065 | 3,064 | 3,140 | 3,163 | 3,194 | 3,099 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Natraj Proteins Ltd corporate filings
- Natraj Proteins Limited re-appoints Shri Sharad Kumar Jain as Whole Time Director for 3 years from October 2026, with no immediate financial impact disclosedCompany Updatelow impact
Cruxal's analysis: Natraj Proteins Limited announced the re-appointment of Shri Sharad Kumar Jain as Whole…
Read the full analysis - Natraj Proteins Limited approves FY2026-27 financial statements with a net profit of INR 3.54 lakh on sales of INR 28.77 crore; Board re-appoints Whole Time Director.AGM/EGMmedium impact
Cruxal's analysis: Natraj Proteins Limited announced the approval of its audited financial statements for…
Read the full analysis - Natraj Proteins Limited's AGM results and resolutions indicate stable voting patterns with majority approval for key proposals, including reappointment and financial statements. The detailed scrutinizer report confirms that all resolutions, including reappointment of directors and ratification of remuneration, were passed with overwhelming majority, reflecting investor confidence. The voting data shows near-unanimous support, with over 99.99% votes in favor, suggesting strong shareholder approval. While the financials remain modest, the positive voting outcome and compliance with regulatory requirements are likely to reinforce investor sentiment, though the company's small market cap and limited financial growth may temper significant re-rating in the near term.AGM/EGMmedium impact
Cruxal's analysis: Natraj Proteins Limited reported AGM voting results with all resolutions passing…
Read the full analysis - Submission of proceedings of the 35th Annual General Meeting of the Company held on Tuesday, 29th September, 2026, pursuant to Regulation 30(2), read with part A of Schedule III of the ....AGM/EGMmedium impact
- The window for trading in shares of the company shall remain close from 1st October,2026 till the completion of 48 hours after declaration of Quarterly and Half-yearly Un-Audited financial ....Insider Trading / SASTlow impact
- Natraj Proteins Ltd dispatches communication to shareholders regarding email registrationCompany Updatelow impact
Cruxal's analysis: Natraj Proteins Ltd has submitted a copy of the letter dispatched to shareholders who…
Read the full analysis - Natraj Proteins Ltd schedules 35th Annual General Meeting for September 29, 2026Company Updatelow impact
Cruxal's analysis: Natraj Proteins Ltd has published a newspaper notice regarding its 35th Annual General…
Read the full analysis - Natraj Proteins Limited Announces 35th Annual General Meeting for September 29, 2026AGM/EGMlow impact
Cruxal's analysis: Natraj Proteins Limited has issued a notice for its 35th Annual General Meeting (AGM) to…
Read the full analysis - Natraj Proteins Ltd schedules 35th Annual General Meeting for September 29, 2026Otherslow impact
Cruxal's analysis: Natraj Proteins Ltd has submitted its 35th Annual Report and notice for the Annual…
Read the full analysis - Natraj Proteins Limited announces 35th Annual General Meeting (AGM) and book closure datesCompany Updatelow impact
Cruxal's analysis: Natraj Proteins Limited has issued a formal notice for its 35th Annual General Meeting…
Read the full analysis - Natraj Proteins Limited Reports Strong Q1 FY2027 Financial Results with Significant Profitability TurnaroundCompany Updatehigh impact
Cruxal's analysis: Natraj Proteins Limited reported a robust performance for the quarter ended 30th June…
Read the full analysis - Natraj Proteins Limited announces re-appointment of Shri Sharad Kumar Jain as Whole Time DirectorCompany Updatelow impact
Cruxal's analysis: Natraj Proteins Limited has formally announced the re-appointment of Shri Sharad Kumar…
Read the full analysis - Natraj Proteins Limited appoints M/s Yogesh Chourasia and Associates as Cost Auditor for FY 2026-27Company Updatelow impact
Cruxal's analysis: Natraj Proteins Limited has formally announced the appointment of M/s Yogesh Chourasia…
Read the full analysis - Natraj Proteins Limited reports strong Q1 FY27 turnaround with net profit of 2.11 croreResulthigh impact
Cruxal's analysis: Natraj Proteins Limited has reported a significant financial turnaround for the quarter…
Read the full analysis - Natraj Proteins Limited Reports Strong Q1 FY27 Turnaround with Profit of 2.11 CroreBoard Meetinghigh impact
Cruxal's analysis: Natraj Proteins Limited has reported a significant financial turnaround for the quarter…
Read the full analysis - Natraj Proteins Limited schedules Board Meeting for August 13, 2026, to approve Q1 FY27 financial resultsBoard Meetinglow impact
Cruxal's analysis: Natraj Proteins Limited has issued a formal intimation regarding a Board Meeting…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.